Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study

被引：0
|
作者：
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] EBMT Study Off, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] European Inst Oncol, Milan, Italy
[5] Ctr Leon Berard, F-69373 Lyon, France
[6] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[7] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[8] Erciyes Univ, Kayseri, Turkey
[9] Portuguese Inst Oncol, Oporto, Portugal
[10] Univ Milan, Milan, Italy
[11] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Pavia, Italy
[12] Ist Ospitalieri Cremona, Cremona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15536
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Consolidative high-dose chemotherapy (HDCT) after conventional-dose chemotherapy (CDCT) as first salvage treatment for male patients (pts) with metastatic germ cell tumors (mGCTs).
    Beausoleil, Michel S.
    Potvin, Kylea R.
    Howson-Jan, Kang
    Ernst, D. Scott
    Stitt, Larry
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [32] Analysis of paclitaxel-based high-dose chemotherapy (Tax HD-VIP) in 18 patients (pts) with relapsed germ-cell tumors (GCT)
    Lorch, A.
    Neubauer, A.
    Schirren, R.
    Hingott, S.
    Hoexter, M.
    Oechsle, K.
    Beyer, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT).
    Kilari, Deepak
    Hari, Parameswaran
    Qayed, Muna
    Fraser, Raphael
    Davila, Omar
    Kumar, Shaji
    Mark, Tomer Martin
    Nieto, Yago
    D'Souza, Anita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [34] Upfront high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (PBSCT) for international germ-cell cancer collaborative group (IGCCCG): Poor prognosis germ cell tumor (GCT) patients
    Banna, Giuseppe Luigi
    Ferrari, Benvenuto
    Bertuzzi, Alexia
    Castagna, Luca
    Piccinelli, Alessandro
    Balzarini, Luca
    Cavina, Raffaele
    Graziotti, Pierpaolo
    Alloisio, Marco
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2005, 16 : 84 - 84
  • [35] Salvage therapy with high-dose chemotherapy (HDCT) and peripheral blood stem cell transplant (PBSCT) in patients with primary mediastinal nonseminomatous germ cell tumors (PMNSGCT).
    Asirwa, F. C.
    Einhorn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Prognostic value of FDG-PET in classification of residual tumors after high-dose (HD) chemotherapy (CTX) of metastatic germ-cell tumors (GCT)
    Pfannenberg, AC
    Dohmen, BM
    Bokemeyer, C
    RADIOLOGY, 1998, 209P : 169 - 169
  • [37] Risk factors for renal failure (RF) during high-dose chemotherapy (HDCT) and outcomes for patients (pts) with relapsed germ-cell tumors (rGCT).
    Zhang, Kevin Juan
    Hanna, Nasser H.
    Abu Zaid, Mohammad Issam
    Abonour, Rafat
    Albany, Costantine
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Maintenance oral etoposide (VP-16) after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors (mGCT).
    Anouti, Bilal
    Akel, Reem
    Althouse, Sandra K.
    Abonour, Rafat
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
    De Giorgi, U.
    Richard, S.
    Badoglio, M.
    Kanfer, E.
    Bourrhis, J. H.
    Nicolas-Virelizier, E.
    Vettenranta, K.
    Lioure, B.
    Martin, S.
    Dreger, P.
    Schuler, M. K.
    Thomson, K.
    Scarpi, E.
    Rosti, G.
    Selle, F.
    Mangili, G.
    Lanza, F.
    Bregni, M.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1910 - 1916
  • [40] Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience
    De Giorgi, U
    Demirer, T
    Wandt, H
    Taverna, C
    Siegert, W
    Bornhauser, M
    Kozak, T
    Papiani, G
    Ballardini, M
    Rosti, G
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 146 - 151
12345